Holen Sie sich die Stockscreener-App
2.2499
1.90%
0.0499
Schlusskurs vom Vortag:
$2.20
Offen:
$2.22
24-Stunden-Volumen:
590.97K
Relative Volume:
0.58
Marktkapitalisierung:
$74.24M
Einnahmen:
$1.23M
Nettoeinkommen (Verlust:
$-28.62M
KGV:
-1.4332
EPS:
-1.5698
Netto-Cashflow:
$-14.11M
1W Leistung:
+7.26%
1M Leistung:
+31.86%
6M Leistung:
-33.08%
1J Leistung:
+25.23%
1-Tages-Spanne:
$2.21
$2.302
1-Wochen-Bereich:
$2.07
$2.302
52-Wochen-Spanne:
$1.58
$3.84
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Firmenname
Nrx Pharmaceuticals Inc
Sektor
Branche
Telefon
484-254-6134
Adresse
1201 ORANGE STREET, WILMINGTON
Compare NRXP vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.245 | 72.75M | 1.23M | -28.62M | -14.11M | -1.5698 |
VRTX
Vertex Pharmaceuticals Inc
|
433.56 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.84 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.14 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.59 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.86 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-02 | Eingeleitet | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Aktie (NRXP) Neueste Nachrichten
NRx Pharmaceuticals Receives FDA Feedback on Preservative-Free Ketamine Label - National Today
NRx Pharmaceuticals Aligns FDA Labeling for Preservative-Free Ketamine Application - citybiz.co
NRx receives preliminary FDA alignment on ketamine labeling By Investing.com - Investing.com Canada
NRx Pharmaceuticals Receives Preliminary Labeling Alignment from FDA for Preservative-Free Ketamine Product - Quiver Quantitative
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling - globenewswire.com
H.C. Wainwright raises NRx Pharmaceuticals stock price target to $45 - Investing.com
NRx Pharmaceuticals, Inc. (NRXPW) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
NRx Pharmaceuticals, Inc. (NRXPW) Stock Price, News, Quote & History - Yahoo! Finance Canada
NRXP Forecast, Price Target & Analyst Ratings | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network - MSN
NRX Pharmaceuticals (HAM:B1Q) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
NRx Pharmaceuticals, Inc. (NRXPW) stock price, news, quote and history - Yahoo Finance Singapore
Hedge Fund Bets: Is NRx Pharmaceuticals Inc backed by strong institutional buyingEarnings Overview Report & Smart Money Movement Tracker - baoquankhu1.vn
AI-Powered 'Depression Thermometer' to Aid Interventional Psychiatry Network - National Today
AI-Powered “Depression Thermometer” to Aid Interventional Psychiatry Network via Strategic Partnership with Emobot for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network - Bitget
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary, Announces Strategic Partnership with Emobot - citybiz
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered 'Depression Thermometer” Across its Interventional Psychiatry Network - The Manila Times
A phone app aims to catch depression relapse between clinic visits - Stock Titan
NRx says FDA will review NRX-100 without new trials - MSN
NRx Pharmaceuticals (NASDAQ:NRXP) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Has Found A Path To Profitability - simplywall.st
Nrx Pharmaceuticals’ Earnings Call Signals High‑Stakes Progress - The Globe and Mail
Published on: 2026-03-29 11:07:47 - baoquankhu1.vn
NRX Pharmaceuticals (HAM:B1Q) Cyclically Adjusted PS Ratio : (As of Apr. 01, 2026) - GuruFocus
Can NRx Pharmaceuticals Inc scale operations efficiently2026 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
NRX Pharmaceuticals (HAM:B1Q) PB Ratio : (As of Mar. 28, 2026) - GuruFocus
Insider Buy: Is NRx Pharmaceuticals Inc a stock for growth or value investors2026 Breakouts & High Accuracy Trade Alerts - baoquankhu1.vn
NRXP Stock Price, Quote & Chart | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2025 Earnings Call Transcript - Insider Monkey
Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT) - The Globe and Mail
NRx Pharmaceuticals, Inc. (NRXP) surpasses Q4 earnings estimates - MSN
NRx Pharmaceuticals (NRXP) Looks to Score Double With ANDA and NDA Filings For NRX-101 - Insider Monkey
NRx Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nrx Pharmaceuticals: Extensive Clinical, Regulatory, and Financial Risks Make Shares Highly Speculative - tipranks.com
5 Best Psychedelic Stocks to Buy in 2026 - Insider Monkey
NRx Pharmaceuticals, Inc. 8-K Filing Details: Company Information, Stock, and Warrants Registered on NASDAQ – March 2026 - Minichart
NRx Pharmaceuticals Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress - Investing News Network
NRx Pharmaceuticals Stockholders Approve Incentive Plan Amendment - TipRanks
NRx Pharmaceuticals stock rating reiterated at Buy by BTIG on FDA progress - Investing.com Australia
NRx Pharmaceuticals (NRXP) investors OK incentive plan and board slate - Stock Titan
NRX Pharmaceuticals Inc (NRXP) Q4 2025 Earnings Call Highlights: Strategic Advances and ... By GuruFocus - Investing.com Canada
NRx Pharmaceuticals' (NRXP) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
NRx Says FDA Finds No Bioequivalence Issues in Ketamine Filing - MyChesCo
NRx Pharmaceuticals (NASDAQ:NRXP) Receives "Buy" Rating from BTIG Research - MarketBeat
NRx Pharmaceuticals (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights Operational Progress - The Globe and Mail
NRx Pharmaceuticals (NASDAQ:NRXP) Releases Earnings Results, Beats Expectations By $0.28 EPS - MarketBeat
NRx Pharmaceuticals Announces Full-Year 2025 Results with Commercial and Regulatory Updates - citybiz.co
NRX Pharmaceuticals’ 2025 Q4 Earnings Call: Shifting Commercialization Strategy and NDA Timeline Clash With Prior Statements - Bitget
NRX Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: NRX Pharmaceuticals Q4 2025 shows operational strides By Investing.com - Investing.com India
Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):